Administrative Claims Analysis of Metanx® in Diabetic Peripheral Neuropathy

Key facts

Sponsor

Pamlab, L.L.C.

Principal Investigator

Ron Wade, RPh, MS

HealthCore, Inc.

Intervention

Metanx® (a medical food)(other)

Enrollment

500 enrolled

Eligibility

25-80 years · All sexes

Timeline

2010 – 2011

Study locations (1)

• HealthCore, Inc., Wilmington, Delaware, United States

Collaborators

HealthCore, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for OBSOLETE: Acquired metabolic neuropathy

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT07496398
  Median and Ulnar Nerve Function in Tattoo Artists
  Gazi University
• ENROLLING BY INVITATIONNANCT07126197
  Using Lymphovenous Bypass to Alleviate Diabetic Peripheral Neuropathy
  National Taiwan University Hospital
• RECRUITINGNANCT07095998
  Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy
  Ka-Wai Ho
• RECRUITINGPHASE2NCT07036796
  Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy
  Ain Shams University
• RECRUITINGNCT06483620
  Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire
  Cairo University
• RECRUITINGNANCT06158529
  High-frequency SCS Versus SCS in the Treatment of Diabetic Peripheral Neuropathic Pain
  Fan BiFa
• RECRUITINGNANCT06287736
  Spinal Cord Stimulation and Small Fiber Peripheral Neuropathy
  Ohio State University
• RECRUITINGNANCT06488963
  The Effect of Cold Therapy on Peripheral Neuropathy
  Koç University

See all trials for OBSOLETE: Acquired metabolic neuropathy →